ONT - JPM FINAL PRESENTATION 9Jan2024.pdf

1、9 January 2024JPM 2024Gordon Sanghera,CEO 2024 Oxford Nanopore Technologies plc.Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose,treat,mitigate,cure,or prevent any disease or condition.DisclaimerThis presentation has been prepared by Oxford Nanopore

2、 Technologies plc(“Oxford Nanopore”)for information purposes only and does not constitute an offer of,or solicitation to purchase or subscribe for,any securities in which such offer or solicitation is unlawful or to any person to whom it is unlawful to make such offer or solicitation.Investors and p

3、rospective investors in the securities of Oxford Nanopore are required to make their own independent investigation and appraisal of the business and financial condition of Oxford Nanopore and consult their own independent financial,legal,tax and business advisors.The information contained in this pr

4、esentation has been provided by Oxford Nanopore and other sources identified therein for the exclusive use of the intended recipient and is highly confidential.No information provided as part of this presentation may be used,copied,reproduced,in whole or part,or otherwise disseminated,directly or in

5、directly,by any recipient to any other person.To the extent permitted by applicable law,no representation or warranty,express or implied,is made by Oxford Nanopore or any member,employee,officer,director,representative,agent or affiliate of Oxford Nanopore as to the accuracy or completeness of any i

6、nformation contained in this presentation.Oxford Nanopore expressly disclaims any and all liability that may be based on any information contained in this presentation and any errors or omissions herein.Oxford Nanopore products are not intended for use for health assessment or to diagnose,treat,miti